Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina

被引:78
作者
Bretillon, Lionel
Diczfalusy, Ulf
Bjoerkhem, Ingernar
Maire, Marie Annick
Martine, Lucy
Joffre, Corinne
Acar, Niyazi
Bron, Alain
Creuzot-Garcher, Catherine
机构
[1] Univ Burgundy, ENESAD, INRA, UMR FLAVIC 1129,Eye & Nutr Res Grp, Dijon, France
[2] Karolinska Univ Hosp Huddinge, Div Clin Chem, Dept Lab Med, Stockholm, Sweden
[3] Univ Hosp, Dept Ophthalmol, Dijon, France
关键词
cholesterol; eye; oxidation; retina;
D O I
10.1080/02713680701231857
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Increasing biological findings argue for the importance of cholesterol-24S-hydroxylase (CYP46A1) in cholesterol homeostasis in cerebral structures. Based on the similarity between the brain and the neural retina, the aim of the current study was to evaluate the expression of CYP46A1 in the mammalian retina. RT-PCR analysis of CYP46A1 in bovine samples revealed the highest expression in the neural retina. The retinal pigment epithelium expressed CYP46A1 gene at a low level while the ciliary body showed no expression. Immunohistochemical evaluation of the posterior pole of rat retina showed that the protein is specifically expressed in neurons, whereas cone-rods photoreceptors were negative for CYP46A1 staining. The metabolite produced by CYP46A1, 24S-hydroxycholesterol, was almost exclusively found in neural retina, the concentration therein being more than 10-fold higher than in the retinal pigment epithelium or the ciliary body. The results of the current study are consistent with our primary hypothesis: the neural retina specifically expresses cholesterol-24S-hydroxylase, a metabolizing enzyme responsible for the removal of cholesterol in neurons. Based on the link between cholesterol-24S-hydroxylase, 24S-hydroxycholesterol, and neurologic disorders, CYP46A1 may be a valuable gene candidate for retinal pathologies like age-related macular degeneration or glaucomas, and 24S-hydroxycholesterol may be involved in the onset of the degenerative processes in these diseases.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 24 条
  • [1] Björkhem I, 1998, J LIPID RES, V39, P1594
  • [2] Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro
    Bjorkhem, I
    Lutjohann, D
    Breuer, O
    Sakinis, A
    Wennmalm, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30178 - 30184
  • [3] On the turnover of brain cholesterol in patients with Alzheimer's disease.: Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells
    Bogdanovica, N
    Bretillon, L
    Lund, EG
    Diczfalusy, U
    Lannfelt, L
    Winblad, B
    Russell, DW
    Björkhem, I
    [J]. NEUROSCIENCE LETTERS, 2001, 314 (1-2) : 45 - 48
  • [4] Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators
    Borroni, B
    Archetti, S
    Agosti, C
    Akkawi, N
    Brambilla, C
    Caimi, L
    Caltagirone, C
    Di Luca, M
    Padovani, A
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 (06) : 747 - 751
  • [5] Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases
    Bretillon, L
    Sidén, Å
    Wahlund, LO
    Lütjohann, D
    Minthon, L
    Crisby, M
    Hillert, J
    Groth, CG
    Diczfalusy, U
    Björkhem, I
    [J]. NEUROSCIENCE LETTERS, 2000, 293 (02) : 87 - 90
  • [6] Bretillon L, 2000, J LIPID RES, V41, P840
  • [7] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [8] Genetic association of CYP46 and risk for Alzheimer's disease
    Combarros, O
    Infante, J
    Llorca, J
    Berciano, J
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (3-4) : 257 - 260
  • [9] Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265
  • [10] Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613